DCPH - Deciphera Pharmaceuticals EPS beats by $0.18 beats on revenue November, 05 2020 04:34 PM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals (DCPH): Q3 GAAP EPS of -$1.13 beats by $0.18.Revenue of $15.45M beats by $8.87M.Press Release For further details see: Deciphera Pharmaceuticals EPS beats by $0.18, beats on revenue